Pharmacodynamic Paradigms in Early-Phase Cancer Clinical Trials Workshop Phase 0 Trials In Oncologic Drug Development Hilary Calvert Northern Institute.
R DEVELOPMENT PROGRAM & STUDY RESULTS Slide # 31.
DOSE SELECTION FOR ANTI-INFECTIVE DRUGS: INDUSTRY PERSPECTIVE Dennis M. Grasela, PharmD, PhD Executive Director, Infectious Diseases Department of Clinical.
